Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trial of Novel OPV2 Vaccine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Newborns at birth (range: 0-3 days of age).~* Mothers that consent for participation in the full length of the study.~* Mothers those are able to understand and comply with planned study procedures.~Exclusion Criteria:~* Mother and newborns who are unable to participate in the full length of the study.~* A diagnosis or suspicion of immunodeficiency disorder either in the newborn or in an immediate family member.~* A diagnosis or suspicion of bleeding disorder that would contraindicate collection of blood by venipuncture.~* Acute diarrhea, infection or illness at the time of enrollment that would require admission to a hospital.~* Acute vomiting and intolerance to liquids within 24 hours before the enrollment visit.~* Receipt of any polio vaccine (OPV or IPV) and Rotavirus Vaccine (RVV) before enrollment based upon documentation or mothers recall.~* Newborns from multiple births. Newborns from multiple births will be excluded to reduce the potential for contact transmission of vaccine poliovirus to siblings. The newborn from a multiple birth who is /are not enrolled would be likely to receive routine immunization and transmit vaccine poliovirus to the enrolled infant.~* Newborns from premature births (\<37 weeks of gestation).

- Gender: ALL
- Minimum Age: 1 Hour
- Maximum Age: 3 Days
- Healthy Volunteers: t

Study Arms:
- Vaccine candidate arm (Type: ACTIVE_COMPARATOR): In this arm, participants will get nOPV2 vaccine candidate 1
- Placebo arm (Type: PLACEBO_COMPARATOR): In this arm, participants will get inactive substance like sucrose in BME media and buffer.

Based on this trial design, predict the completion outcome and termination type (if applicable).